For you to qualify for the Medicare GLP-1 Bridge, a provider must submit a prior authorization request that attests the beneficiary meets the following criteria: The beneficiary is prescribed the requested drug to reduce excess body weight and maintain weight reduction in combination with current and ongoing lifestyle modification including structured nutrition and physical activity consistent with the applicable FDA approved label, AND The beneficiary is at least eighteen (18) years of age and has a BMI greater than or equal to thirty-five (35) at the time of initiation of GLP-1 therapy, or The beneficiary is at least eighteen (18) years of age and has a BMI greater than or equal to thirty (30) at the time of initiating GLP-1 therapy with a diagnosis of one or more of the following: (A) heart failure with preserved ejection fraction, (B) uncontrolled hypertension (defined as systolic blood pressure above 140 mm Hg or diastolic blood pressure above 90 mm Hg, despite concurrent treatment with two antihypertensive medications), or (C) chronic kidney disease stage 3a or above, or The beneficiary is at least eighteen (18) years of age and has a BMI greater than or equal to twenty-seven (27) at the time of initiating GLP-1 therapy with a diagnosis of one or more of the following: (A) pre-diabetes (as defined by American Diabetes Association guidelines), (B) previous myocardial infarction, (C) previous stroke, or (D) symptomatic peripheral artery disease

4 strategies to preserve lean mass: eat 1.2-2.0g protein per kg body weight daily, distribute protein evenly across meals (30g+ each), perform resistance training 2-3 times weekly, and eat protein first at every meal
This pattern reflects the current medical understanding of obesity as a chronic condition requiring ongoing management, similar to how conditions like high blood pressure or diabetes are treated
Known for its luxury skincare services, Clinic Dermatech offers customized IV drip treatments tailored to your unique skin concerns
Beyond calories, another factor (one that is frequently overlooked) is diet quality
Semenza and a colleague have just published a report in the journal Criminology examining whether taking GLP-1 drugs could help curb violence